Beamtree Holdings Share Price and Company Fundamentals
Last traded: Today at 3:22 AM
Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks. The company offers Activity BarCoding, and on-premise solution that captures customized data across organizations to support various operations; Ainsoff Deterioration Index, an application that enables acuity monitoring across the whole organization; operational services in health and social services data analytics; and clinical coding, auditing, education and training services. It also provides PICQ, a quality assessment tool for clinically coded data; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; RippleDown Expert that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; and RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors. In addition, the company offers RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and workforce wellbeing collaborative program. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
1.18
Dividend yield
-
Beta
1.75
Market cap
$49.41M
Enterprise value
$46.71M
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Full time employees | 97 |
| Website | https://beamtree.com.au |
| Mailing address | 5 Blue Street Suite 2, Level 10 North Sydney NSW 2060 Australia |
| Phone / Fax | 61 2 8313 9990 / 61 2 8583 3040 |
Dividends
More: Beamtree Holdings Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Beamtree Holdings paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BMT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Beamtree Holdings.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Marek Stepniak | Chief Executive Officer | ||
| Mr. Mark McLellan | COO & CFO | ||
| Ms. Cheryl McCullagh | Chief Product Officer and Chief Clinical & Innovation Officer | ||
| Mr. Stephen Morgan | Chief Technology Officer | ||
| Ms. Kateena Mills | Head of People & Culture | ||
| Mr. Michael Reakes | General Manager | ||
| Ms. Jennifer Nobbs | Head of International Advisory | ||
| Mr. Evan Simmons | Head of Diagnostics | ||
| Ms. Larissa Mason | Head of Clinical Decision Support | ||
| Mr. Stephen Badham | Head of Coding & Data Quality |
Profitability and management effectiveness
Profit margin
-21.54%
Operating margin
-21.77%
Return on assets
-6.83%
Return on equity
-13.83%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Beamtree Holdings is 49.41M and its enterprise value is 46.71M. The enterprise value to revenue ratio of BMT is 1.63. The enterprise value to EBITDA ratio of BMT is -9.99.
The BMT's stocks Beta value is 1.75 making it 75% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Beamtree Holdings (BMT)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Beamtree Holdings (ASX:BMT) Frequently Asked Questions
1. What is Beamtree Holdings's Stock Symbol?
Beamtree Holdings trades on ASX under the ticker symbol "BMT".
2. What is Beamtree Holdings's stock price today?
One share of BMT stock can currently be purchased for approximately $0.17.
3. How can I contact Beamtree Holdings?
Beamtree Holdings's mailing address is 5 Blue Street Suite 2, Level 10 North Sydney NSW 2060 Australia. The company can be reached via phone at 61 2 8313 9990.
4. What is Beamtree Holdings's official website?
The official website of Beamtree Holdings is https://beamtree.com.au.